Phase Holographic Imaging_Old

DISCOVER the Power of Time-Lapse Cytometry
HoloMonitor® M4
HoloMonitor® M4
EXPLORE HoloMonitor® Wound Healing Assay
EXPLORE HoloMonitor® Wound Healing Assay
Current methods force scientists to study life’s fundamental building block when it is dying. PHI’s non-destructive Holo­Monitor technology allows the long-term behavior of living cells to be observed and quantified without toxic stains.
With the first Holo­Monitor® instrument introduced in 2011, the company today offers a range of products and applications for label-free and quantitative live-cell analysis. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. 

PHI is actively expanding the customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies. Since 2014 the stock is publicly traded on AktieTorget.